Our findings may have therapeutic relevance, as inhibition of AMPK by Compound C sensitizes leukemia cells to the cytotoxic effects of the GLI1/2 inhibitor GANT-61 in vitro. The gene discussed is PRKAA1; the disease is leukemia.